6533b838fe1ef96bd12a3e18
RESEARCH PRODUCT
Biosimilar and generic formulations of novel antidiabetic drugs: the role of liraglutide in clinical pharmacology of type 2 diabetes.
Rizzo ManfrediFrancesco CosentinoChristos Mantzorossubject
Diabetes Mellitus Type 2Drugs GenericHumansHypoglycemic AgentsPharmacology (medical)General MedicineGeneral Pharmacology Toxicology and PharmaceuticsLiraglutideBiosimilar PharmaceuticalsGlucagon-Like Peptide-1 ReceptorBiosimilar GLP-1 diabetes generics liraglutide treatmentyear | journal | country | edition | language |
---|---|---|---|---|
2022-08-05 | Expert review of clinical pharmacology |